The World Health Organization said on Tuesday it has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing, paving the way for a second Chinese shot to be used in poor countries.
Follow Israel Hayom on Facebook and Twitter
A WHO emergency listing is a signal to national regulators of a product's safety and efficacy and will allow the Sinovac shot to be included in COVAX, the global program providing vaccines mainly for poor countries, which faces major supply problems due to curbs on Indian exports.
The WHO's independent panel of experts said it recommended Sinovac's vaccine for adults over 18.
The WHO in May gave approval to China's Sinopharm vaccine, the first non-Western vaccine to receive backing from the UN agency.
